Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 13, 2008
Boston Scientific welcomed two-year results from the SPIRIT III clinical trial, presented at the 2008 EuroPCR Scientific Program in Barcelona.
-
May 13, 2008
Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention
-
May 8, 2008
"We are very pleased with the decision by the Canadian Federal Court dismissing this case," said Boston Scientific's Chief Operating Officer.
-
May 8, 2008
ALTRUA™ is Company's most advanced pacemaker and delivers enhanced therapies while maintaining its small size and battery longevity.
-
May 7, 2008Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...
-
May 5, 2008
Ruling from World Intellectual Property Organization (WIPO) arbitration panel finds no infringement
-
Apr 24, 2008
MADIT-CRT trial designed to test whether CRT-Ds can slow the progression of heart failure in heart attack survivors
-
Apr 23, 2008
Award recognizes Boston Scientific's successful use of electronic transactions to improve supply chain efficiency for customers and suppliers
-
Apr 21, 2008
"We continued to make good progress during the quarter, particularly in our efforts to bring expenses in line with revenues," said CEO Jim Tobin.
-
Apr 17, 2008
Company plans to launch product immediately